Drug Utilization Review (DUR) Provider Communications - 2019
- RETRODUR INTERVENTION NOTICE: Use of Antipsychotic Medications in Patients Less Than 21 Years of Age and Metabolic Monitoring - November 22, 2019 (PDF)
- RETRODUR INTERVENTION NOTICE: Concurrent Use of Antipsychotic and Opioid Medications as Related to the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act - November 5, 2019 (PDF)
- Health Commerce Blast: REMINDER: Substance Use Disorder Drug Treatment, Medicaid Managed Care (MMC) and Fee-for-Service (FFS) Coverage (PDF)
- RETRODUR INTERVENTION NOTICE: Use of Antipsychotic Medications in Children Related to the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act - October 21, 2019 (PDF)
- RETRODUR INTERVENTION NOTICE: Concurrent Gabapentinoid and Opioid Utilization - June 1, 2019 (PDF)
- RETRODUR INTERVENTION NOTICE: Use of Hydroxyurea in Patients with Sickle Cell Diseases - June 1, 2019 (PDF)